BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 29455021)

  • 1. Effect of dopamine receptor D4 (DRD4) haplotypes on general psychopathology in patients with eating disorders.
    Gervasini G; González LM; Gamero-Villarroel C; Mota-Zamorano S; Carrillo JA; Flores I; García-Herráiz A
    Gene; 2018 May; 654():43-48. PubMed ID: 29455021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of dopamine polymorphisms on the risk for anorexia nervosa and associated psychopathological features.
    Gervasini G; Gordillo I; García-Herráiz A; Flores I; Jiménez M; Monge M; Carrillo JA
    J Clin Psychopharmacol; 2013 Aug; 33(4):551-5. PubMed ID: 23775054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of COMT Val158Met Polymorphism with Psychopathological Symptoms in Patients with Eating Disorders.
    Gervasini G; Gonzalez LM; Mota-Zamorano S; Gamero-Villarroel C; Carrillo JA; Flores I; Garcia-Herraiz A
    Curr Mol Med; 2018; 18(1):65-70. PubMed ID: 29879886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BDNF genetic variability modulates psychopathological symptoms in patients with eating disorders.
    Gamero-Villarroel C; Gordillo I; Carrillo JA; García-Herráiz A; Flores I; Jiménez M; Monge M; Rodríguez-López R; Gervasini G
    Eur Child Adolesc Psychiatry; 2014 Aug; 23(8):669-79. PubMed ID: 24292283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anorexia nervosa, perfectionism, and dopamine D4 receptor (DRD4).
    Bachner-Melman R; Lerer E; Zohar AH; Kremer I; Elizur Y; Nemanov L; Golan M; Blank S; Gritsenko I; Ebstein RP
    Am J Med Genet B Neuropsychiatr Genet; 2007 Sep; 144B(6):748-56. PubMed ID: 17440932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of
    Gamero-Villarroel C; González LM; Rodríguez-López R; Albuquerque D; Carrillo JA; García-Herráiz A; Flores I; Gervasini G
    Brain Behav; 2017 Sep; 7(9):e00784. PubMed ID: 28948079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible association of the DRD4 gene with a history of attention-deficit/hyperactivity disorder in women with bulimia nervosa.
    Yilmaz Z; Kaplan AS; Levitan RD; Zai CC; Kennedy JL
    Int J Eat Disord; 2012 May; 45(4):622-5. PubMed ID: 22271608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epistatic interactions implicating dopaminergic genes in bulimia nervosa (BN): relationships to eating- and personality-related psychopathology.
    Thaler L; Groleau P; Badawi G; Sycz L; Zeramdini N; Too A; Israel M; Joober R; Bruce KR; Steiger H
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):120-8. PubMed ID: 22683321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A DRD4/BDNF gene-gene interaction associated with maximum BMI in women with bulimia nervosa.
    Kaplan AS; Levitan RD; Yilmaz Z; Davis C; Tharmalingam S; Kennedy JL
    Int J Eat Disord; 2008 Jan; 41(1):22-8. PubMed ID: 17922530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence.
    Vereczkei A; Demetrovics Z; Szekely A; Sarkozy P; Antal P; Szilagyi A; Sasvari-Szekely M; Barta C
    PLoS One; 2013; 8(6):e66592. PubMed ID: 23840506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variants in the Obesity-Linked FTO gene locus modulates psychopathological features of patients with Anorexia Nervosa.
    González LM; García-Herráiz A; Mota-Zamorano S; Flores I; Albuquerque D; Gervasini G
    Gene; 2021 May; 783():145572. PubMed ID: 33737121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epistatic interactions involving DRD2, DRD4, and COMT polymorphisms and risk of substance abuse in women with binge-purge eating disturbances.
    Steiger H; Thaler L; Gauvin L; Joober R; Labbe A; Israel M; Kucer A
    J Psychiatr Res; 2016 Jun; 77():8-14. PubMed ID: 26950642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic markers and personality traits in eating disorders--preliminary results].
    Abrahám I; Bokor S; Fenyvesi I; Molnár D; Vörös V; Osváth P; Gáti A
    Neuropsychopharmacol Hung; 2007 Dec; 9(4):175-81. PubMed ID: 18510261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between DRD2 and DRD4 Polymorphisms and Eating Disorders in an Italian Population.
    Ceccarini MR; Fittipaldi S; Ciccacci C; Granese E; Centofanti F; Dalla Ragione L; Bertelli M; Beccari T; Botta A
    Front Nutr; 2022; 9():838177. PubMed ID: 35369087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia.
    Mercader JM; Ribasés M; Gratacòs M; González JR; Bayés M; de Cid R; Badía A; Fernández-Aranda F; Estivill X
    Genes Brain Behav; 2007 Nov; 6(8):706-16. PubMed ID: 17376155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A season-of-birth/DRD4 interaction predicts maximal body mass index in women with bulimia nervosa.
    Levitan RD; Kaplan AS; Davis C; Lam RW; Kennedy JL
    Neuropsychopharmacology; 2010 Jul; 35(8):1729-33. PubMed ID: 20336060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants in dopamine pathways affect personality dimensions displayed by patients with eating disorders.
    González LM; Mota-Zamorano S; García-Herráiz A; López-Nevado E; Gervasini G
    Eat Weight Disord; 2021 Feb; 26(1):93-101. PubMed ID: 31786797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence for strong recent positive selection favoring the 7 repeat allele of VNTR in the DRD4 gene.
    Naka I; Nishida N; Ohashi J
    PLoS One; 2011; 6(8):e24410. PubMed ID: 21909391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DRD4 gene and obsessive compulsive disorder: do symptom dimensions have specific genetic correlates?
    Taj M J RJ; Viswanath B; Purushottam M; Kandavel T; Janardhan Reddy YC; Jain S
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Mar; 41():18-23. PubMed ID: 23127570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of NEGR1 genetic variability on psychological traits of patients with eating disorders.
    Gamero-Villarroel C; González LM; Gordillo I; Carrillo JA; García-Herráiz A; Flores I; Rodríguez-López R; Gervasini G
    Pharmacogenomics J; 2015 Jun; 15(3):278-83. PubMed ID: 25245582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.